查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1439905

臨床化學分析儀 - 全球市場考量、競爭狀況、市場預測 (2030)

Clinical Chemistry Analyzers - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: 按訂單生產 | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

全球臨床生化分析儀市場規模將於 2022 年達到 123.8 億美元，到 2030 年將達到 163.9 億美元，預計在 2024-2030 年預測期內複合年增長率為 4.82%。 由於慢性病的流行和人口老化的增加等因素，市場呈現顯著成長。 此外，隨著產品發佈和批准數量的增加，設備技術的快速進步，對疾病早期診斷的需求迅速增加，即時檢測的重要性和意識不斷增強，市場上主要參與者的存在等。市場對臨床生化分析儀的要求。 因此，預計在 2024 年至 2030 年的預測期內，市場將以顯著的複合年增長率成長。

臨床生化分析儀市場動態

臨床化學分析儀市場的關鍵驅動因素之一是全球癌症、泌尿系統疾病和傳染病等各種慢性疾病的增加。

例如，根據世界衛生組織 (WHO) (2022) 的數據，慢性病每年導致近 4,100 萬人死亡，佔全球死亡人數的 74%。 慢性病的主要類型是心臟病和中風等心血管疾病、癌症、慢性阻塞性肺病和氣喘等慢性呼吸道疾病以及糖尿病。

相同數據也顯示了 2020 年全球癌症病例數。 最常見的癌症是乳癌（226萬例）、肺癌（221萬例）、大腸癌（193萬例）、攝護腺癌（141萬例）、皮膚癌（120萬例）和胃癌（1.09萬例）。 癌症發生率的增加增加了對可用於癌症診斷的分析設備的需求，導致市場需求旺盛。

此外，隨著人口老化的加劇，慢性病的盛行率將會增加，臨床生化分析儀的需求也會增加。 世界衛生組織2022年發佈的一項研究表明，到2030年，六分之一的人將超過60歲。 根據同一項研究，60歲及以上的人口將從2020年的10億增加到2030年的14億。 此外，預計到 2050 年這一數字將增至 21 億。 不斷增長的老年人口容易患上多種慢性疾病，導致對臨床檢測的需求增加。 因此，臨床生化分析儀市場預計在預測期內將出現高速成長。

此外，與臨床化學分析儀相關的產品發佈和批准的增加將推動未來幾年對這些設備的需求。 例如，2022 年7 月，醫療電子產品供應商EDAN Instruments, Inc. 推出了一款基於即時護理(POC) 螢光的產品，能夠分析超過45 個參數，涵蓋從血氣到電解質到CO 血氧測定法的所有參數。OX血氣/化學分析系統 i20 已發佈。

因此，上述因素將在 2024-2030 年預測期內推動整個臨床生化分析儀市場的發展。

然而，缺乏訓練有素、技術熟練的專業人員以及臨床生化分析儀的高成本可能會給臨床生化分析儀市場的成長帶來挑戰。

在 COVID-19 大流行期間，臨床化學分析儀市場受到了中等程度的影響。 隨著世界各國政府實施嚴格的封鎖規則以遏制感染傳播，市場耗盡了供應鏈和原材料等資源，從而減少了所有醫療設備的生產。 此外，患者和醫生也推遲了許多選擇性手術、檢查和疾病診斷，以阻止感染傳播，導致醫院和診所的住院人數減少。 然而，隨著COVID-19疫苗的開發、封鎖規定的放鬆、經濟形勢的正常化，正常的醫療護理，如定期到醫院和診所進行治療、管理和診斷等，已不再可能。隨著服務的恢復，臨床化學分析儀市場的產品需求重回正軌。

臨床生化分析儀細分市場分析

在臨床化學分析儀市場的產品類型細分市場中，分析儀細分市場預計將在 2023 年佔重要的收入佔有率。 其主要原因是該細分市場提供的優勢，例如慢性病的增加、市場上技術先進的產品的可用性以及產品上市和批准的增加。

本報告研究和分析了全球臨床生化分析儀市場，提供市場規模和預測、驅動因素和挑戰、公司和產品概況等。

目錄

第1章臨床生化分析儀市場報告簡介

第 2 章臨床化學分析儀市場執行摘要

  • 調查範圍
  • 市場概覽
  • 競爭評估
  • 財務基準

第3章監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第4章臨床生化分析儀市場主要因素分析

  • 臨床化學分析儀市場驅動因素
    • 慢性病流行
    • 人口老化負擔日益加重
    • 現場檢測的重要性和意識不斷增強
    • 臨床化學分析儀技術的進步
  • 臨床生化分析儀市場的抑制因素與挑戰
    • 缺乏訓練有素、技術熟練的專業人員
    • 臨床化學分析儀成本高
  • 臨床化學分析儀市場機遇
    • 對早期準確診斷的需求和認識不斷提高
    • 將人工智慧融入設備

第 5 章臨床生化分析儀市場的波特五力分析

第6章COVID-19對臨床生化分析儀市場的影響分析

第7章臨床生化分析儀市場佈局

  • 依產品類型
    • 分析器
    • 試劑
    • 其他
  • 按檢定類型
    • 肝臟面板
    • 電解質面板
    • 甲狀腺功能面板
    • 血脂概況
  • 按技術
    • 全自動
    • 半自動
  • 按最終用戶
    • 醫院
    • 診斷實驗室
  • 按地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他領域

第 8 章臨床生化分析儀市場：全球公司佔有率分析 - 3 至 5 家主要公司

第9章臨床生化分析儀市場公司及產品概況

  • Abbott
  • Beckman Coulter, Inc.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthcare Private Limited
  • Thermo Fisher Scientific Inc.
  • Sysmex Europe SE.
  • ELITechGroup
  • F. Hoffmann-La Roche Ltd.
  • HORIBA Medical
  • Johnson & Johnson Services, Inc.
  • Randox Laboratories Ltd.
  • Ortho Clinical Diagnostics.
  • Nova Biomedical
  • BioSystems Diagnostics Pvt. Ltd.
  • DiaSys Diagnostic Systems GmbH
  • Diatron.
  • EKF Diagnostics Holdings plc
  • Medica Corporation.
  • Trivitron Healthcare
  • Shenzhen New Industries Biomedical Engineering Co., Ltd.

第10章KOL觀看次數

第 11 章專案方法

第 12 章關於 DelveInsight

第 13 章免責聲明與聯絡我們

Product Code: DIMDCL0582

CLINICAL CHEMISTRY ANALYZERS MARKET BY PRODUCT TYPE (ANALYZERS, REAGENTS, AND OTHERS), BY TYPE OF TEST (LIVER PANELS, ELECTROLYTE PANELS, THYROID FUNCTION PANELS, LIPID PROFILES, AND OTHERS), BY TECHNOLOGY (FULLY-AUTOMATED AND SEMI- AUTOMATED), BY END USER (HOSPITAL, DIAGNOSTIC LABORATORIES, AND OTHERS), AND BY GEOGRAPHY IS EXPECTED TO ADVANCE AT A RESPECTABLE CAGR FORECAST till 2030 OWING TO THE INCREASING PREVALENCE OF VARIOUD CHORNIC DIESAES AND ESCALTING BURDEN OF GERATRIC POPULATION ACROSS THE GLOBE

The global clinical chemistry analyzers market was valued at USD 12.38 billion in 2022 and will grow at a CAGR of 4.82% during the forecast period from 2024 to 2030 in order to reach USD 16.39 billion by 2030. The clinical chemistry analyzers market is observing a remarkable market growth due to the factors such as the growing prevalence of chronic diseases and the rising burden of geriatric population. Furthermore, the surging demand of early diagnosis of disease, the increasing importance and awareness of point-of-care testing, surging technological advancements in the devices along with the increasing product launches and approvals, presence of key players in the market, and other factors will create a requisite for the clinical chemistry analyzers in the market. Therefore, the market for clinical chemistry analyzers is estimated to grow at a substantial CAGR during the forecast period from 2024 to 2030.

CLINICAL CHEMISTRY ANALYZERS MARKET DYNAMICS:

One of the key aspect for driving the clinical chemistry analyzers market is the rising number of various chronic disease such as cancers, urological, infectious diseases, and others across the globe.

For instance, according to the World Health Organization (WHO) 2022, chronic diseases kills nearly 41 million people each year, equivalent to 74% of all deaths globally. The main types of chronic diseases are cardiovascular diseases such as heart attacks and stroke, cancers, chronic respiratory diseases such as chronic obstructive pulmonary disease and asthma, diabetes, and others.

Also, the same source listed the incidence of cancer in 2020, globally. The most common form of cancers reported was of breast cancer with 2.26 million cases, lung cancer -2.21 million cases, colon and rectum cancer with 1.93 million cases, prostate cancer with 1.41 million cases, skin cancer 1.20 million cases, and stomach cancer with 1.09 million cases, globally. This increasing incidence of cancers will increase the demand of analyzers as these devices can be employed while diagnosis of the cancers, thereby leading to its increased demand in the market.

Moreover, the rising burden of geriatric population will increase the number of prevalence of various chronic disease, in turn increasing the demand of the clinical chemistry analyzers. As per the study concluded by WHO in 2022, it was clearly stated that by the year 2030, around 1 in 6 people will be over the age of 60. The same source revealed that the number of people over the age of 60 will reach 1.4 billion in the year 2030, up from 1 billion in 2020. The numbers are further projected to rise to 2.1 billion by 2050. The increasing elderly population is vulnerable to several chronic diseases, resulting in high demand for clinical tests. Thus, the clinical chemistry analyzers market is expected to witness high growth over the forecast period.

Moreover, rising product launches and approvals pertaining to the clinical chemistry analyzers will propel the demand of the device in the upcoming years. For instance, in July 2022, EDAN Instruments, Inc., a medical equipment provider that offers medical electronic equipment, launched its point-of-care (POC) fluorescence-based CO-OX blood gas and chemistry analysis system, i20, with the capacity to analyze over 45 parameters, covering everything from blood gases to electrolytes to CO-oximetry.

Therefore, the factors stated above collectively will drive the overall clinical chemistry analyzers market during the forecast period from 2024-2030.

However, lack of trained and skilled professionals, high cost of clinical chemistry analyzer devices, and others may prove to be challenging factors for clinical chemistry analyzers market growth.

The clinical chemistry analyzers market was moderately impacted during the period of COVID- 19 pandemic. In order to curb the spread of infection the government across the globe imposed strict lockdown rules, resulting in the shortage of supply chains, raw materials, and other resources in the market, leading to the decreased manufacturing of all the medical devices. Moreover, the patients and physicians postponed many elective surgeries, testing, and diagnosis of diseases in order to stop the spread of the infection, thereby decreasing the number of in-patient visits in hospitals and clinics. However, vaccine development of COVID-19 has initiated the process of economic recovery with the easing of lockdown restrictions and the return of normalcy in the economic landscape, which has initiated the process of resumption of regular healthcare services such as regular out-patients visits for treatments, management, and diagnosis in hospitals and clinics, thereby bringing the demand for products on track in the clinical chemistry analyzers market.

CLINICAL CHEMISTRY ANALYZERS MARKET SEGMENT ANALYSIS:

Clinical Chemistry Analyzers Market by Product Type (Analyzers, Reagents, and Others), Type of Test (Liver Panels, Electrolyte Panels, Thyroid Function Panels, Lipid Profiles, and Others), Technology (Fully-Automated and Semi- Automated), End User (Hospital, Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the clinical chemistry analyzers market, the analyzers segment is expected to have a significant revenue share in the year 2023. This was primarily owing to the rising number of chronic disease, availability of technological advanced products in the market, rising product launches and approvals in the market, and other advantages offered by the segment.

The analyzers are the instruments that examine the samples, such as blood serum and urine. The automation in analyzers has become universal in clinical laboratories around the world. This advancement will aid in reducing healthcare costs, provides accuracy and reliability. Thus, the hospitals and laboratories rely on automated analyzers in order to maintain profitability as well.

Moreover, the presence of technological advanced products in the market will in-turn increase the demand of analyzers. For instance, Atellica CH 930 Analyzer from Siemens Healthineers is an apt example of a technologically improved Clinical Chemistry analyzer. Atellica Solution integrates immunoassay and clinical chemistry analyzer. With Potentiometric, Photometric, and Turbidimetric Assay Technologies, Atellica CH 930 comes with a feature of auto reflex testing, which means it will perform additional tests based on the first test result. It's a mid-volume clinical chemistry analyzer, capable of running a maximum of 1800 tests per hour.

Furthermore, the increasing product launches in the market will bolster the demand of analyzers in the market. For instance, in September 2022, Roche Diagnostics India launched the Cobas pure integrated solutions analyzer with a smarter system that is particularly suitable for numerous laboratories and hospitals in India. The analyzer allows for better utilization of space and increased delivery of high-medical-value tests for greater patient benefits.

Therefore, owing to the above-mentioned factors, the demand of the analyzers will rises, thereby the category is expected to witness a considerable growth eventually contributing to the overall growth of the global clinical chemistry analyzers market during the forecast period.

NORTH AMERICA IS EXPECTED TO DOMINATE THE OVERALL CLINICAL CHEMISTRY ANALYZERS MARKET:

Among all the regions, North America is expected to dominate the global clinical chemistry analyzers in the year 2023 and is expected to do the same during the forecast period from 2024-2030.

This can be ascribed to the increasing prevalence of chronic diseases, rising importance of diagnosis and specifically point-of care testing, surging geriatric population in the region, and the presence of key market players in the region, and other factors contribute to the growth of the clinical chemistry analyzers market in North America.

For instance, according to the Centers for Disease Control and Prevention (CDC) 2022, it was stated that the chronic diseases are the leading cause of death and disability every year in the United States. The rising number of chronic diseases in the nation enhances to the growth of clinical chemistry analyzers in the North American region. Thus, the high burden of the target and chronic diseases in the region and increasing demand for early diagnostics are the other major factors that are driving the growth of the studied market in the North American region.

Additionally, according to the Canadian Cancer Society 2022 report, about 229,200 new cancer cases were diagnosed in Canada in 2022, and on average, 628 Canadians were diagnosed with cancer every day, which is further expected to increase in the future. Also, as per the same report, lung, breast, colorectal, and prostate cancer were the most diagnosed types of cancer in Canada. Thus, the increasing prevalence of chronic diseases will increase the demand of clinical chemistry analyzers in the upcoming years as these analyzers are used to conduct assays on the clinical samples such as blood, plasma, urine, and cerebrospinal fluid in order to detect the presence of analytes relating to any disease.

Furthermore, the increasing product launches of technological advanced products in the local market, rising investments by the key players in the region, and other activities by the key players in the region will drive the demand of clinical chemistry analyzers in the North America during the forecast period of 2022 - 2028. For instance, in February 2022, Thermo Fisher Scientific partnered with Mindray to provide customers in the United States and Canada with two clinical chemistry analyzers for drug screening in clinical and forensic laboratories. Thermo Fisher and Mindray entered into an agreement to offer the FDA-cleared and Health Canada-approved BS-480 (400 tests/hour) and BA-800M (800 tests/hour) analyzers to toxicology labs.

Therefore, the interplay of the aforementioned factors above would provide a conducive growth environment for the North American region in the clinical chemistry analyzers market.

CLINICAL CHEMISTRY ANALYZERS MARKET KEY PLAYERS:

Some of the key market players operating in the clinical chemistry analyzers market includes Abbott, Beckman Coulter, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Sysmex Europe SE., ELITechGroup, F. Hoffmann-La Roche Ltd., HORIBA Medical, Johnson & Johnson Services, Inc., Randox Laboratories Ltd., Ortho Clinical Diagnostics., Nova Biomedical, BioSystems Diagnostics Pvt. Ltd., DiaSys Diagnostic Systems GmbH, Diatron., EKF Diagnostics Holdings plc, Medica Corporation., Trivitron Healthcare, Shenzhen New Industries Biomedical Engineering Co., Ltd., and others.

RECENT DEVELOPMENTAL ACTIVITIES IN CLINICAL CHEMISTRY ANALYZERS MARKET:

In May 2022, Mindray launched the BS-600M, a powerful, efficient chemistry analyzer that is designed to empower medium-volume laboratories with increased productivity, efficiency, and reliability.

In April 2022, Sysmex Europe launched its new three-part differential system, the XQ-320 XQ-Series Automated Hematology Analyzer. With reliable technology and a new level of usability, the XQ-320 brings excellence in quality to a diverse range of clinical laboratory environments.

In January 2020, Sysmex invested in Astrego Diagnostics for the development of urinalysis solutions.

KEY TAKEAWAYS FROM THE CLINICAL CHEMISTRY ANALYZERS MARKET REPORT STUDY

  • Market size analysis for current clinical chemistry analyzers market size (2023), and market forecast for 5 years (2024-2030)
  • The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the clinical chemistry analyzers market.
  • Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
  • Key companies dominating the global clinical chemistry analyzers market.
  • Various opportunities available for the other competitor in the clinical chemistry analyzers market space.
  • What are the top performing segments in 2023? How these segments will perform in 2030.
  • Which is the top-performing regions and countries in the current clinical chemistry analyzers market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for clinical chemistry analyzers market growth in the coming future?

TARGET AUDIENCE WHO CAN BE BENEFITED FROM THIS CLINICAL CHEMISTRY ANALYZERS MARKET REPORT STUDY

  • Clinical chemistry analyzers products providers
  • Research organizations and consulting companies
  • Clinical chemistry analyzers -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and Traders dealing in clinical chemistry analyzers
  • Various end users who want to know more about the clinical chemistry analyzers market and latest technological developments in the clinical chemistry analyzers market.

FREQUENTLY ASKED QUESTIONS FOR CLINICAL CHEMISTRY ANALYZERS MARKET:

1. What are clinical chemistry analyzers?

The clinical chemistry analyzers are the devices which run assays on the clinical samples such as blood, plasma, urine, and cerebrospinal fluid in order to detect the presence of analytes relating to disease or drugs.

2. What is the global market for Clinical Chemistry Analyzers?

The global clinical chemistry analyzers market was valued at USD 12.38 billion in 2022 and will grow at a CAGR of 4.82% during the forecast period from 2024 to 2030 in order to reach USD 16.39 billion by 2030.

3. What are the drivers for global clinical chemistry analyzers market?

The clinical chemistry analyzers market is witnessing a positive market growth owing to the factors such as the growing prevalence of chronic diseases, rising burden of geriatric population, increasing importance and awareness of point-of-care testing, surging technological advancements in the devices, increasing product launches and approvals, presence of key players in the market, and others will create an exigency for the clinical chemistry analyzers market.

4. Who are the key players operating in the global clinical chemistry analyzers market?

Some of the key market players operating in the clinical chemistry analyzers market includes Abbott, Beckman Coulter, Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc., Sysmex Europe SE., ELITechGroup, F. Hoffmann-La Roche Ltd., HORIBA Medical, Johnson & Johnson Services, Inc., Randox Laboratories Ltd., Ortho Clinical Diagnostics., Nova Biomedical, BioSystems Diagnostics Pvt. Ltd., DiaSys Diagnostic Systems GmbH, Diatron., EKF Diagnostics Holdings plc, Medica Corporation., Trivitron Healthcare, Shenzhen New Industries Biomedical Engineering Co., Ltd., and others.

5. Which region has the highest share in clinical chemistry analyzers market?

Among all the regions, North America is estimated to amass the significant revenue share in the global clinical chemistry analyzers market. This can be ascribed to the increasing prevalence of chronic diseases, rising importance of diagnosis and specifically point-of care testing, and the presence of key market players in the region are the reasons which acts as a supportive factor for the North America clinical chemistry analyzers market growth.

Table of Contents

1. Clinical Chemistry Analyzers Market Report Introduction

2. Clinical Chemistry Analyzers Market Executive Summary

  • 2.1 Scope of the Study
  • 2.2 Market at Glance
  • 2.3 Competitive Assessment
  • 2.4 Financial Benchmarking

3. Regulatory Analysis

  • 3.1 The United States
  • 3.2 Europe
  • 3.3 Japan
  • 3.4 China

4. Clinical Chemistry Analyzers Market Key Factors Analysis

  • 4.1 Clinical Chemistry Analyzers Market Drivers
    • 4.1.1 Growing prevalence of chronic diseases
    • 4.1.2 Rising burden of geriatric population
    • 4.1.3 Increasing importance and awareness of point-of-care testing
    • 4.1.4 Rising technological advancements in clinical chemistry analyzer
  • 4.2 Clinical Chemistry Analyzers Market Restraints and Challenges
    • 4.2.1 Lack of trained and skilled professionals
    • 4.2.2 High cost of clinical chemistry analyzer devices
  • 4.3 Clinical Chemistry Analyzers Market Opportunities
    • 4.3.1 Increasing demand and awareness about early and accurate diagnosis
    • 4.3.2 Incorporation of artificial intelligence in the devices

5. Clinical Chemistry Analyzers Market Porter's Five Forces Analysis

  • 5.1 Bargaining Power of Suppliers
  • 5.2 Bargaining Power of Consumers
  • 5.3 Threat of New Entrants
  • 5.4 Threat of Substitutes
  • 5.5 Competitive Rivalry

6. COVID-19 Impact Analysis on Clinical Chemistry Analyzers Market

7. Clinical Chemistry Analyzers Market Layout

  • 7.1 By Product Type
    • 7.1.1 Analyzers
    • 7.1.2 Reagents
    • 7.1.3 Others
  • 7.2 By Type of Test
    • 7.2.1 Liver Panels
    • 7.2.2 Electrolyte Panels
    • 7.2.3 Thyroid Function Panels
    • 7.2.4 Lipid Profiles
    • 7.2.5 Others
  • 7.3 By Technology
    • 7.3.1 Fully-Automated
    • 7.3.2 Semi- Automated
  • 7.4 By End User
    • 7.4.1 Hospital
    • 7.4.2 Diagnostic Laboratories
    • 7.4.3 Others
  • 7.5 By Geography
    • 7.5.1 North America
      • 7.5.1.1 United States Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.1.2 Canada Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.1.3 Mexico Clinical Chemistry Analyzers Market in USD million (2021-2030)
    • 7.5.2 Europe
      • 7.5.2.1 France Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.2.2 Germany Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.2.3 United Kingdom Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.2.4 Italy Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.2.5 Spain Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.2.6 Rest of Europe Clinical Chemistry Analyzers Market in USD million (2021-2030)
    • 7.5.3 Asia-Pacific
      • 7.5.3.1 China Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.3.2 Japan Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.3.3 India Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.3.4 Australia Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.3.5 South Korea Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.3.6 Rest of Asia Pacific Clinical Chemistry Analyzers Market in USD million (2021-2030)
    • 7.5.4 Rest of the World (RoW)
      • 7.5.4.1. Middle East Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.4.2 Africa Clinical Chemistry Analyzers Market in USD million (2021-2030)
      • 7.5.4.3 South America Clinical Chemistry Analyzers Market in USD million (2021-2030)

8. Clinical Chemistry Analyzers Market Global Company Share Analysis - Key 3-5 Companies

9. Clinical Chemistry Analyzers Market Company and Product Profiles

  • 9.1 Abbott
    • 9.1.1. Company Overview
    • 9.1.2. Company Snapshot
    • 9.1.3. Financial Overview
    • 9.1.4 Product Listing
    • 9.1.5. Entropy
  • 9.2 Beckman Coulter, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Company Snapshot
    • 9.2.3. Financial Overview
    • 9.2.4 Product Listing
    • 9.2.5. Entropy
  • 9.3 Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    • 9.3.1. Company Overview
    • 9.3.2. Company Snapshot
    • 9.3.3. Financial Overview
    • 9.3.4 Product Listing
    • 9.3.5. Entropy
  • 9.4 Siemens Healthcare Private Limited
    • 9.4.1. Company Overview
    • 9.4.2. Company Snapshot
    • 9.4.3. Financial Overview
    • 9.4.4 Product Listing
    • 9.4.5. Entropy
  • 9.5 Thermo Fisher Scientific Inc.
    • 9.5.1. Company Overview
    • 9.5.2. Company Snapshot
    • 9.5.3. Financial Overview
    • 9.5.4 Product Listing
    • 9.5.5. Entropy
  • 9.6 Sysmex Europe SE.
    • 9.6.1. Company Overview
    • 9.6.2. Company Snapshot
    • 9.6.3. Financial Overview
    • 9.6.4 Product Listing
    • 9.6.5. Entropy
  • 9.7 ELITechGroup
    • 9.7.1. Company Overview
    • 9.7.2. Company Snapshot
    • 9.7.3. Financial Overview
    • 9.7.4 Product Listing
    • 9.7.5. Entropy
  • 9.8 F. Hoffmann-La Roche Ltd.
    • 9.8.1. Company Overview
    • 9.8.2. Company Snapshot
    • 9.8.3. Financial Overview
    • 9.8.4 Product Listing
    • 9.8.5. Entropy
  • 9.9 HORIBA Medical
    • 9.9.1. Company Overview
    • 9.9.2. Company Snapshot
    • 9.9.3. Financial Overview
    • 9.9.4 Product Listing
    • 9.9.5. Entropy
  • 9.10 Johnson & Johnson Services, Inc.
    • 9.10.1. Company Overview
    • 9.10.2. Company Snapshot
    • 9.10.3. Financial Overview
    • 9.10.4 Product Listing
    • 9.10.5. Entropy
  • 9.11 Randox Laboratories Ltd.
    • 9.11.1. Company Overview
    • 9.11.2. Company Snapshot
    • 9.11.3. Financial Overview
    • 9.11.4 Product Listing
    • 9.11.5. Entropy
  • 9.12 Ortho Clinical Diagnostics.
    • 9.12.1. Company Overview
    • 9.12.2. Company Snapshot
    • 9.12.3. Financial Overview
    • 9.12.4 Product Listing
    • 9.12.5. Entropy
  • 9.13 Nova Biomedical
    • 9.13.1. Company Overview
    • 9.13.2. Company Snapshot
    • 9.13.3. Financial Overview
    • 9.13.4 Product Listing
    • 9.13.5. Entropy
  • 9.14 BioSystems Diagnostics Pvt. Ltd.,
    • 9.14.1. Company Overview
    • 9.14.2. Company Snapshot
    • 9.14.3. Financial Overview
    • 9.14.4 Product Listing
    • 9.14.5. Entropy
  • 9.15 DiaSys Diagnostic Systems GmbH
    • 9.15.1. Company Overview
    • 9.15.2. Company Snapshot
    • 9.15.3. Financial Overview
    • 9.15.4 Product Listing
    • 9.15.5. Entropy
  • 9.16 Diatron.
    • 9.16.1. Company Overview
    • 9.16.2. Company Snapshot
    • 9.16.3. Financial Overview
    • 9.16.4 Product Listing
    • 9.16.5. Entropy
  • 9.17 EKF Diagnostics Holdings plc
    • 9.17.1. Company Overview
    • 9.17.2. Company Snapshot
    • 9.17.3. Financial Overview
    • 9.17.4 Product Listing
    • 9.17.5. Entropy
  • 9.18 Medica Corporation.
    • 9.18.1. Company Overview
    • 9.18.2. Company Snapshot
    • 9.18.3. Financial Overview
    • 9.18.4 Product Listing
    • 9.18.5. Entropy
  • 9.19 Trivitron Healthcare
    • 9.19.1. Company Overview
    • 9.19.2. Company Snapshot
    • 9.19.3. Financial Overview
    • 9.19.4 Product Listing
    • 9.19.5. Entropy
  • 9.20 Shenzhen New Industries Biomedical Engineering Co., Ltd.
    • 9.20.1. Company Overview
    • 9.20.2. Company Snapshot
    • 9.20.3. Financial Overview
    • 9.20.4 Product Listing
    • 9.20.5. Entropy

10. KOL Views

11. Project Approach

12. About DelveInsight

13. Disclaimer & Contact Us

List of Tables

  • Table 1 Competitive Analysis
  • Table 2 COVID-19 Impact Analysis on Clinical Chemistry Analyzers Market
  • Table 3 Clinical Chemistry Analyzers Market Analysis in Global (2021-2030)
  • Table 4 Clinical Chemistry Analyzers Market Analysis in Global by Product Type (2021-2030)
  • Table 5 Clinical Chemistry Analyzers Market Analysis in Global by Type of Test (2021-2030)
  • Table 6 Clinical Chemistry Analyzers Market Analysis in Global by Technology (2021-2030)
  • Table 7 Clinical Chemistry Analyzers Market Analysis in Global by End-user (2021-2030)
  • Table 8 Clinical Chemistry Analyzers Market Analysis in Global by Geography (2021-2030)
  • Table 9 Clinical Chemistry Analyzers Market Analysis in North America (2021-2030)
  • Table 10 Clinical Chemistry Analyzers Market Analysis in North America by Country (2021-2030)
  • Table 11 Clinical Chemistry Analyzers Market Analysis in the US (2021-2030)
  • Table 12 Clinical Chemistry Analyzers Market Analysis in Canada (2021-2030)
  • Table 13 Clinical Chemistry Analyzers Market Analysis in Mexico (2021-2030)
  • Table 14 Clinical Chemistry Analyzers Market Analysis in Europe (2021-2030)
  • Table 15 Clinical Chemistry Analyzers Market Analysis in Europe by Country (2021-2030)
  • Table 16 Clinical Chemistry Analyzers Market Analysis in France (2021-2030)
  • Table 17 Clinical Chemistry Analyzers Market Analysis in Germany (2021-2030)
  • Table 18 Clinical Chemistry Analyzers Market Analysis in the UK (2021-2030)
  • Table 19 Clinical Chemistry Analyzers Market Analysis in Italy (2021-2030)
  • Table 20 Clinical Chemistry Analyzers Market Analysis in Spain (2021-2030)
  • Table 21 Clinical Chemistry Analyzers Market Analysis in Rest of Europe (2021-2030)
  • Table 22 Clinical Chemistry Analyzers Market Analysis in Asia-Pacific (2021-2030)
  • Table 23 Clinical Chemistry Analyzers Market Analysis in Asia-Pacific by Country (2021-2030)
  • Table 24 Clinical Chemistry Analyzers Market Analysis in China (2021-2030)
  • Table 25 Clinical Chemistry Analyzers Market Analysis in Japan (2021-2030)
  • Table 26 Clinical Chemistry Analyzers Market Analysis in India (2021-2030)
  • Table 27 Clinical Chemistry Analyzers Market Analysis in Australia (2021-2030)
  • Table 28 Clinical Chemistry Analyzers Market Analysis in South Korea (2021-2030)
  • Table 29 Clinical Chemistry Analyzers Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Table 30 Clinical Chemistry Analyzers Market Analysis in Rest of World (2021-2030)
  • Table 31 Clinical Chemistry Analyzers Market Analysis in Rest of World by Region (2021-2030)
  • Table 32 Clinical Chemistry Analyzers Market Analysis in the Middle East (2021-2030)
  • Table 33 Clinical Chemistry Analyzers Market Analysis in Africa (2021-2030)
  • Table 34 Clinical Chemistry Analyzers Market Analysis in South America (2021-2030)

List of Figures

  • Figure 1 Competitive Analysis
  • Figure 2 COVID-19 Impact Analysis on Clinical Chemistry Analyzers Market
  • Figure 3 Clinical Chemistry Analyzers Market Analysis in Global (2021-2030)
  • Figure 4 Clinical Chemistry Analyzers Market Analysis in Global by Product Type (2021-2030)
  • Figure 5 Clinical Chemistry Analyzers Market Analysis in Global by Type of Test (2021-2030)
  • Figure 6 Clinical Chemistry Analyzers Market Analysis in Global by Technology (2021-2030)
  • Figure 7 Clinical Chemistry Analyzers Market Analysis in Global by End-user (2021-2030)
  • Figure 8 Clinical Chemistry Analyzers Market Analysis in Global by Geography (2021-2030)
  • Figure 9 Clinical Chemistry Analyzers Market Analysis in North America (2021-2030)
  • Figure 10 Clinical Chemistry Analyzers Market Analysis in North America by Country (2021-2030)
  • Figure 11 Clinical Chemistry Analyzers Market Analysis in the US (2021-2030)
  • Figure 12 Clinical Chemistry Analyzers Market Analysis in Canada (2021-2030)
  • Figure 13 Clinical Chemistry Analyzers Market Analysis in Mexico (2021-2030)
  • Figure 14 Clinical Chemistry Analyzers Market Analysis in Europe (2021-2030)
  • Figure 15 Clinical Chemistry Analyzers Market Analysis in Europe by Country (2021-2030)
  • Figure 16 Clinical Chemistry Analyzers Market Analysis in France (2021-2030)
  • Figure 17 Clinical Chemistry Analyzers Market Analysis in Germany (2021-2030)
  • Figure 18 Clinical Chemistry Analyzers Market Analysis in the UK (2021-2030)
  • Figure 19 Clinical Chemistry Analyzers Market Analysis in Italy (2021-2030)
  • Figure 20 Clinical Chemistry Analyzers Market Analysis in Spain (2021-2030)
  • Figure 21 Clinical Chemistry Analyzers Market Analysis in Rest of Europe (2021-2030)
  • Figure 22 Clinical Chemistry Analyzers Market Analysis in Asia-Pacific (2021-2030)
  • Figure 23 Clinical Chemistry Analyzers Market Analysis in Asia-Pacific by Country (2021-2030)
  • Figure 24 Clinical Chemistry Analyzers Market Analysis in China (2021-2030)
  • Figure 25 Clinical Chemistry Analyzers Market Analysis in Japan (2021-2030)
  • Figure 26 Clinical Chemistry Analyzers Market Analysis in India (2021-2030)
  • Figure 27 Clinical Chemistry Analyzers Market Analysis in Australia (2021-2030)
  • Figure 28 Clinical Chemistry Analyzers Market Analysis in South Korea (2021-2030)
  • Figure 29 Clinical Chemistry Analyzers Market Analysis in Rest of Asia-Pacific (2021-2030)
  • Figure 30 Clinical Chemistry Analyzers Market Analysis in Rest of World (2021-2030)
  • Figure 31 Clinical Chemistry Analyzers Market Analysis in Rest of World by Region (2021-2030)
  • Figure 32 Clinical Chemistry Analyzers Market Analysis in the Middle East (2021-2030)
  • Figure 33 Clinical Chemistry Analyzers Market Analysis in Africa (2021-2030)
  • Figure 34 Clinical Chemistry Analyzers Market Analysis in South America (2021-2030)
  • Figure 35 Market Drivers
  • Figure 36 Market Barriers
  • Figure 37 Market Opportunities
  • Figure 38 PORTER's Five Force Analysis